Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Zhejiang Ruibang Pharmaceutical Co., LTD, operating under the brand name Ruibang, is a Chinese pharmaceutical manufacturer established in 1956. The company specializes in the research, development, manufacturing, and sale of a diverse portfolio of Active Pharmaceutical Ingredients (APIs) and finished drug products. Their product range includes antibiotics such as meleumycin, mupirocin, and fusidic acid; immunosuppressants like cyclosporine A; lipid-lowering agents such as simvastatin and lovastatin; and various mineral gluconates (e.g., calcium, zinc, magnesium, potassium, ferrous, copper gluconates) which also serve as nutritional supplements. Ruibang also produces riboflavin (Vitamin B2) and methylbenactyzine bromide. The company holds certifications from the U.S. FDA, Chinese GMP, and European GMP, indicating adherence to international quality standards. They also produce food-grade gluconate series and are involved in nutraceutical markets.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Ruibang.